This is unexpected given the large body of data implicating activation of both Raf/MEK/ERK and PI3K/Akt signalling downstream of oncogenic K-Ras as essential in JMML and lung cancer pathogenesis. Here, KRAS is linked to juvenile myelomonocytic leukemia.